Home  |  Top News  |  Most Popular  |  Video  |  Multimedia  |  News Feeds  |  Feedback
  Medicine  |  Nature & Earth  |  Biology  |  Technology & Engineering  |  Space & Planetary  |  Psychology  |  Physics & Chemistry  |  Economics  |  Archaeology
Top > Medicine, Health Care > Stroke Drug Kills Bacteria That… >

Stroke Drug Kills Bacteria That Cause Ulcers And Tuberculosis

Published: December 20, 2012.
Released by Federation of American Societies for Experimental Biology  

Bethesda, MD—A drug currently being used to treat ischemic strokes may prove to be a significant advance in the treatment of tuberculosis and ulcers. In a new research report appearing online in The FASEB Journal, a compound called ebselen effectively inhibits the thioredoxin reductase system in a wide variety of bacteria, including Helicobacter pylori which causes gastric ulcers and Mycobacterium tuberculosis which causes tuberculosis. Thioredoxin and thioredoxin reductase proteins are essential for bacteria to make new DNA, and protect them against oxidative stress caused by the immune system. Targeting this system with ebselen, and others compounds like it, represents a new approach toward eradicating these bacteria.

"This new antibacterial principle provides better chances of surviving an infection," said Arne Holmgren, M.D., Ph.D., a researcher involved in the work from the Division of Biochemistry in the Department of Medical Biochemistry and Biophysics, at Karolinska Institutet in Stockholm, Sweden. "Since ebselen is also an antioxidant, the present mechanism can be described as a 'two for the price of one' antioxidant action in inflammation, and specific targeting of multi-resistant bacterial complications and sepsis."

Building on previous observations where ebselen has shown antibacterial properties against some bacteria, Holmgren and colleagues hypothesized that the bacteria sensitive to ebselen relied solely on thioredoxin and thioredoxin reductase for essential cellular processes. They investigated this by testing it on strains of E. coli with deletions in the genes for thioredoxin, thioredoxin reductase and the glutaredoxin system. They found that strains with deletions in the genes coding for glutaredoxin system were much more sensitive than normal bacteria. Researchers further tested ebselen against Helicobacter pylori and Mycobacterium tuberculosis, which both naturally lack the glutaredoxin system and are frequently resistant to many commonly used antibiotics, and found both to be sensitive to ebselen.

"As rapidly as these organisms evolve, we need new drugs sooner rather than later," said Gerald Weissmann, M.D., Editor-in-Chief of The FASEB Journal. "The fact that these scientists have found a new target for killing some of the most resistant bacteria is great news, but the fact that we already have at least one drug which we could possibly use now makes the news even better."




The above story is based on materials provided by Federation of American Societies for Experimental Biology.

Translate this page: Chinese French German Italian Japanese Korean Portuguese Russian Spanish


comments powered by Disqus


Related »

Infections 
3/24/14 

Instant Immune Booster Dramatically Improves Outcome of Bacterial Meningitis And Pneumonia
Latent 
3/26/15 
How the Human Immune System Keeps TB at Bay
COLUMBUS, Ohio - A new tissue culture model using human white blood cells shows how people with a latent …
Clinical 
8/22/12 
NIH Uses Genome Sequencing to Help Quell Bacterial Outbreak in Clinical Center
For six months last year, a deadly outbreak of antibiotic-resistant bacteria kept infection-control specialists at the National Institutes of …
Sickle 
5/23/14 
Bacterial Adaptation Contributes to Pneumococcal Threat in Sickle Cell Disease Patients
Researchers have identified differences in the genetic code of pneumococcal bacteria that may explain why it poses such a …
Host 
3/26/12 
Using Viruses to Beat Superbugs
Viruses that can target and destroy bacteria have the potential to be an effective strategy for tackling hard-to-treat bacterial …
Meningococcal 
3/26/15 
Harmless Bacteria May Be Helpful Against Meningococcal Outbreaks
Nasal drops of harmless bacteria can inhibit a related bug that sometimes causes meningococcal disease, according to new findings …
Essential 
9/15/12 
Discovery of Essential Genes for Drug-resistant Bacteria Reveals New, High-value Drug Targets
BUFFALO, N.Y. -- Biomedical scientists collaborating on translational research at two Buffalo institutions are reporting the discovery of a …
Asl 
7/4/12 
Cystic Fibrosis Makes Airways More Acidic, Reduces Bacterial Killing
The human airway is a pretty inhospitable place for microbes. There are numerous immune defense mechanisms poised to kill …
More » 
 
© Newsline Group  |  About  |  Privacy Policy  |  Feedback  |  Mobile